Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
公司代码TDACU
公司Translational Development Acquisition Corp
CEOHoffman (Michael B)
网址
常见问题
Translational Development Acquisition Corp(TDACU)的当前股价是多少?
Translational Development Acquisition Corp(TDACU)的当前股价是 11.000。
Translational Development Acquisition Corp的股票代码是什么?
Translational Development Acquisition Corp的股票代码是TDACU。
Translational Development Acquisition Corp股票的52周最高点是多少?
Translational Development Acquisition Corp股票的52周最高点是10.900。
Translational Development Acquisition Corp股票的52周最低点是多少?
Translational Development Acquisition Corp股票的52周最低点是10.000。
Translational Development Acquisition Corp的市值是多少?
Translational Development Acquisition Corp的市值是--。
Translational Development Acquisition Corp的净利润是多少?
Translational Development Acquisition Corp的净利润为-485.55K。
现在Translational Development Acquisition Corp(TDACU)的股票是买入、持有还是卖出?
根据分析师评级,Translational Development Acquisition Corp(TDACU)的总体评级为--,目标价格为--。
Translational Development Acquisition Corp(TDACU)股票的每股收益(EPS TTM)是多少
Translational Development Acquisition Corp(TDACU)股票的每股收益(EPS TTM)是--。